APPLICATIONS PUBLISHED 8 JUNE 2005

Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
Alza Corp 1536767*

Biodegradable compsn with prolonged release of the biologically active compound and preparation thereof
Pliva-Lachema 1536768*

Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
Novadel Pharma 1536769*

Thermolabile liposome with a controlled release temperature
Max-Planck-Gesellschaft zuer Foerderung der Wissenschaften 1536770*

Phopsholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
Arcamore, Federico; Subissi, Alessandro 1536771*

A pharmaceutical compsn of small-sized liposomes and method of preparation
Monte Verde; Zodiac Produtos Farmac Uticos 1536772*

Method of manufacturing albumin microspheres comprising antisense oligonucleotides (oligomers) to NF-KB
The Corporation of Mercer University 1536773*

Taste masked dosage forms and processes for their preparation
Ranbaxy Laboratories 1536774*

Compsns comprising HMG-CoA reductase inhibitor
Novartis 1536775*

Derivatives of 1,3-cyclic propanediol phosphate and their action as cell stimulants
Yeda Research and Development 1536776*

Use of NF-Kappa B inhibitors for the treatment of mastitis
Janssen Pharmaceutica 1536777*

Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity
Universitair Medisch Centrum Utrecht; Universiteit Utrecht Holding 1536778*

Treatment of metastatic breast cancer with anthracyclines and taxanes
The University of Manitoba 1536779*

Oral liquid tolterodine compsn
Pharmacia Corp 1536780*

Nutritional or pharmaceutical compsns for increasing the creatine response of organisms
NV Nutrica 1536781*

Synergistic combination of an alpha-2-delta ligand and a PDEV inhibitor for use in the treatment of pain
Pfizer 1536782*

Solid formulations comprising an indolinone compound
Pharmacia Italia 1536783*

Hetero biaryl derivatives as matric metalloproteinase inhibitors
Warner-Lambert 1536784*

Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure
Bethesda Pharmaceuticals 1536785*

Combination of an allosteric inhibitor of matric metalloproteinase-13 with celecoxib or valdecoxib
Warner-Lambert 1536786*

Imidazole alkaloids from Lepidium meyenii and methods of usage
Pure World Botanicals 1536787*

Pharmaceutical solid dosage forms exhibiting reproducible drug release profile
Pharmacia & Upjohn 1536788*

Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
Zentaris 1536789*

Oxadiazoles as modulators of metabotropic glutamate receptor-5
AstraZeneca; NPS Pharmaceuticals 1536790*

Sustained-release tablet comprising reboxetine
Pharmacia 1536791*

Pramipexole once-daily dosage form
Pharmacia 1536792*

Pharmaceutical compsn comprising FK506 derivatives and the IR use for the treatment of allergic diseases
Sucampo Pharmaceuticals 1536793*

Treatment of rheumatoid arthritis by inhibition of PDE4
Merck & Co; Merck Frosst Canada 1536794*

Inverse agonists acting at virus-encoded G protein-coupled receptors
Vrije Universiteit van Amsterdam 1536795*

N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion
Janssen Pharmaceutica 1536796*

1-amino-4-phenyl-4-benzyloxymethylpiperidine derivatives and related compounds as neurokinin-1 (NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
Schering 1536797*

3-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
ALTANA Pharma 1536798*

Novel 2-amino-4-oxoquinazolones as LXR nuclear receptor binding compounds with partial agonistic properties
PheneX Pharmaceuticals 1536799*

Synergistic interaction of abacavir and alovudine
Medivir 1536800*

Topical compsns and methods for treatment of adverse effects of ionising radiation
The Quigley Corp 1536801*

Shortening of hospital stay and improving survival in patients with chronic kidney disease
Abbott Laboratories 1536802*

Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment
Kobernhavns Universiteit 1536803*

2"-C-methyl-3"-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
Idenix (Cayman); Universita Degli Studi de Cagliari 1536804*

Nutritional compsns comprising a non-glucose carbohydrate or pectin and soluble fibre
Novartis 1536805*

Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation
Institut National de la Recherche Agronomique 1536806*

Non-polymeric haematopoietic cell clots for delivery of active agents
The Brigham's and Women's Hospital 1536807*